Aphria Enters into Supplier Agreement with Shoppers Drug Mart
Conference call December 4, 2017 at 5:30 pm ET
Leamington, Ontario – December 4, 2017 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) today announced that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart.
Under the terms of the agreement the Company will supply Aphria branded medical cannabis products. Subject to Health Canada’s approval of Shoppers Drug Mart’s application to be a licensed producer, the products will be sold online, as Canadian regulations currently restrict the sale of medical cannabis in retail pharmacies.
“We have an impeccable record cultivating and producing high-quality, medical-grade cannabis,” said Vic Neufeld, CEO of Aphria. “These traits make us a strong partner for an organization looking to serve and support Canadian patients.”
Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada, Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. Aphria is committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders.